• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
  • View Item
  •   LillOA Home
  • Liste des unités
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Apathy as a feature of prodromal alzheimer's ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article original
DOI :
10.1002/gps.4161
PMID :
24953008
Permalink :
http://hdl.handle.net/20.500.12210/16180
Title :
Apathy as a feature of prodromal alzheimer's disease: an fdg-pet adni study
Author(s) :
Delrieu, Julien [Auteur]
Desmidt, Thomas [Auteur]
Camus, Vincent [Auteur]
Sourdet, Sandrine [Auteur]
Boutoleau-Bretonniere, Claire [Auteur]
Mullin, Emmanuel [Auteur]
Vellas, Bruno [Auteur]
Payoux, Pierre [Auteur]
Lebouvier, Thibaud [Auteur] orcid refId
Journal title :
International journal of geriatric psychiatry
Abbreviated title :
Int. J. Geriatr. Psychiatr.
Volume number :
30
Pages :
470-477
Publication date :
2015-05-01
ISSN :
0885-6230
English keyword(s) :
Alzheimer''s disease neuroimaging initiative (ADNI)
Alzheimer''s disease
biomarker
FDG-PET
apathy
mild cognitive impairment
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
OBJECTIVE: The goal of this study is to evaluate brain metabolism in mild cognitive impairment (MCI) patients with and without apathy (as determined by the Neuropsychiatric Inventory Questionnaire). METHODS: Baseline data ...
Show more >
OBJECTIVE: The goal of this study is to evaluate brain metabolism in mild cognitive impairment (MCI) patients with and without apathy (as determined by the Neuropsychiatric Inventory Questionnaire). METHODS: Baseline data from 65 MCI participants (11 with apathy and 54 without) from the Alzheimer's Disease (AD) Neuroimaging Initiative study were analyzed. All participants underwent a comprehensive cognitive and neuropsychiatric assessment, volumetric MRI and measures of cerebral glucose metabolism applying (18)F-fluorodeoxyglucose positron emission tomography at baseline. The presence of apathy at baseline was determined by the Neuropsychiatric Inventory Questionnaire. RESULTS: There was no difference between apathy and apathy-free MCI patients regarding cognitive assessment and neuropsychiatric measures when apathy-specific items were removed. Cerebrovascular disease load and cerebral atrophy were equivalent in both groups. Compared with the apathy-free MCI patients, MCI patients with apathy had significantly decreased metabolism in the posterior cingulate cortex. CONCLUSIONS: The presence of apathy in MCI patients is associated with AD-specific pattern of brain metabolic defect. These results could suggest that apathy belongs to the spectrum of prodromal AD symptoms.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
CNRS
Inserm
Université de Lille
Collections :
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
Research team(s) :
Troubles cognitifs dégénératifs et vasculaires
Submission date :
2019-11-27T13:34:29Z
Université de Lille

Mentions légales
Université de Lille © 2017